Page last updated: 2024-11-01

nifedipine and Hematologic Neoplasms

nifedipine has been researched along with Hematologic Neoplasms in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liesveld, J1
Duerst, R1
Rapoport, A1
Constine, L1
Abboud, C1
Packman, C1
Wedow, L1
Zwetsch, L1
McKenna, B1
Linder, T1
Silverman, W1
Swift, S1
Rowe, J1
DiPersio, J1

Other Studies

1 other study available for nifedipine and Hematologic Neoplasms

ArticleYear
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of

1999